Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 

Federal Register Search Results

CDER - March 2004

Federal Register, Volume 69 (2004)

3/1/04

Total Hits: 1

[1] fr01mr04N Determination That Cytoxan (Cyclophosphamide for Injection), 2

Size: 7976 , Score: 338 , HTML

3/2/04

Total Hits: 0


3/3/04

Total Hits: 0


3/4/04

Total Hits: 0


3/5/04

Total Hits: 2

[1] fr05mr04N Draft Guidance for Industry on Labeling for Combined Oral

Size: 4623 , Score: 544 , HTML

[2] fr05mr04N Diabetes: Targeting Safe and Effective Prevention and Treatment;

Size: 8872 , Score: 491 , HTML

3/8/04

Total Hits: 2

[1] fr08mr04N Guidance for Federal Agencies and State and Local Governments;

Size: 5466 , Score: 523 , HTML

[2] fr08mr04N Determination That LOVENOX (Enoxaparin Sodium) 90 Milligrams/0.6

Size: 5207 , Score: 355 , HTML

3/9/04

Total Hits: 2

[1] fr09mr04N Draft Guidance for Industry on Vaccinia Virus--Developing Drugs

Size: 5472 , Score: 708 , HTML

[2] fr09mr04N Antimicrobial Drug Development; Public Workshop

Size: 4487 , Score: 547 , HTML

3/10/04

Total Hits: 1

[1] fr10mr04R Medical Device Reports; Reports of Corrections and Removals;

Size: 25060 , Score: 1000 , HTML

3/11/04

Total Hits: 0


3/12/04

Total Hits: 0


3/15/04

Total Hits: 6

[1] fr15mr04N Report on the Performance of Drug and Biologics Firms in

Size: 10554 , Score: 489 , HTML

[2] fr15mr04N Determination of Regulatory Review Period for Purposes of Patent

Size: 6703 , Score: 427 , HTML

[3] fr15mr04N Determination of Regulatory Review Period for Purposes of Patent

Size: 6754 , Score: 426 , HTML

[4] fr15mr04N Determination of Regulatory Review Period for Purposes of Patent

Size: 6780 , Score: 425 , HTML

[5] fr15mr04N Determination of Regulatory Review Period for Purposes of Patent

Size: 6924 , Score: 424 , HTML

[6] fr15mr04N Determination That DIAZEPAM Injection United States Pharmacopeia

Size: 5364 , Score: 352 , HTML

3/16/04

Total Hits: 0


3/17/04

Total Hits: 0


3/18/04

Total Hits: 1

[1] fr18mr04R Prescription Drug Marketing Act of 1987; Prescription Drug

Size: 20899 , Score: 737 , HTML

3/19/04

Total Hits: 1

[1] fr19mr04N Determination of Regulatory Review Period for Purposes of Patent

Size: 6908 , Score: 425 , HTML

3/22/04

Total Hits: 1

[1] fr22mr04N Agency Information Collection Activities; Proposed Collection;

Size: 12327 , Score: 284 , HTML

3/23/04

Total Hits: 1

[1] fr23mr04R Change of Address; Technical Amendment

Size: 3019 , Score: 230 , HTML

3/24/04

Total Hits: 4

[1] fr24mr04N Advisory Committee for Pharmaceutical Science; Notice of Meeting

Size: 4085 , Score: 221 , HTML
[2] fr24mr04P Drug Labeling; Sodium Labeling for Over-the-Counter Drugs
Size: 24898 , Score: 213 , HTML
[3] fr24mr04R Drug Labeling; Sodium Labeling for Over-the-Counter Drugs;
Size: 59533 , Score: 192 , HTML
[4] fr24mr04R Drug Labeling; Orally Ingested Over-the-Counter Drug Products
Size: 72976 , Score: 188 , HTML

3/25/04

Total Hits: 0


3/26/04

Total Hits: 0


3/29/04

Total Hits: 0


3/30/04

Total Hits: 4

[1] fr30mr04N International Conference on Harmonisation; Draft Guidance on E2E

Size: 7510 , Score: 452 , HTML
[2] fr30mr04N International Conference on Harmonisation; Draft Guidance on Q5E
Size: 8588 , Score: 440 , HTML
[3] fr30mr04N Oncologic Drugs Advisory Committee; Notice of Meeting
Size: 4159 , Score: 219 , HTML
[4] fr30mr04N Nonprescription Drugs Advisory Committee and the Dermatologic and
Size: 4104 , Score: 219 , HTML

3/31/04

Total Hits: 0



Next Month
Back To TOC

© 1997-2006 Betterchem Corp.